Ginkgo Bioworks Holdings

DNA.US
Healthcare · Biotechnology
7.70
+0.25 (+3.36%)
USD · NYSE

Company Information

Company Name
Ginkgo Bioworks Holdings
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
ISIN: US37611X2099
CIK: 0001830214
CUSIP: 37611X100
Currency: USD
Full Time Employees: 485
Phone: 877 422 5362
Fiscal Year End: December
IPO Date: Apr 19, 2021
Description:

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Address:

27 Drydock Avenue, Boston, MA, United States, 02210

People

Directors & Officers

Name Title Year Born
Dr. Jason Kelly Ph.D. Co-Founder, Co-COO, CEO & Director 1981
Dr. Reshma P. Shetty Co-Founder, President & Director 1981
Mr. Steven P. Coen CPA Chief Financial Officer 1966
Mr. Thomas Knight Jr. Founder NA
Mr. Austin Che Ph.D. Co-Founder & Head of Strategy NA
Mr. Bartholomew Canton Ph.D. Co-Founder & CTO NA
Ms. Jennifer Wipf Co-Chief Operating Officer NA
Ms. Karen Tepichin General Counsel & Secretary NA
Mr. Daniel Marshall Senior Manager of Communications & Ownership NA
Mr. Brian O'sullivan Head of Commercial NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 17, 2026 Steven P Coen N/A Sale 324.00 $7.95 $2.58K
Apr 13, 2026 Steven P Coen N/A Sale 33.17K $6.41 $212.63K
Apr 10, 2026 Barry Canton N/A Sale 124.73K $6.43 $801.99K
Apr 10, 2026 Reshma P Shetty N/A Sale 124.73K $6.43 $801.99K
Apr 09, 2026 Barry Canton N/A Sale 13.12K $6.40 $83.94K
Apr 09, 2026 Jason R Kelly N/A Sale 109.77K $6.40 $702.51K
Apr 09, 2026 Reshma P Shetty N/A Sale 13.12K $6.40 $83.94K
Apr 08, 2026 Barry Canton N/A Sale 13.16K $6.93 $91.16K
Apr 08, 2026 Jason R Kelly N/A Sale 97.02K $6.93 $672.31K
Apr 08, 2026 Reshma P Shetty N/A Sale 13.16K $6.93 $91.16K
Mar 16, 2026 Steven P Coen N/A Sale 708.00 $6.74 $4.77K
Jan 20, 2026 Steven P Coen N/A Sale 972.00 $8.92 $8.67K
Dec 15, 2025 Steven P Coen N/A Sale 736.00 $8.89 $6.54K
Oct 17, 2025 Steven P Coen N/A Sale 1.31K $13.65 $17.91K
Oct 01, 2025 Steven P Coen N/A Sale 5.61K $15.00 $84.14K
Jul 17, 2025 Steven P Coen N/A Sale 1.08K $9.84 $10.67K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 3.64M Mar 31, 2026 5.58% $0.00 1.93%
Viking Global Investors LP 3.58M Mar 31, 2026 5.48% $0.06 0.00%
Vanguard Group Inc 2.90M Dec 31, 2025 4.44% $0.00 16.95%
Baillie Gifford & Co Limited. 2.39M Mar 31, 2026 3.66% $0.02 0.00%
Erste Asset Management GmbH 1.95M Mar 31, 2026 2.98% $0.10 -2.61%
Vanguard Capital Management, LLC 1.91M Mar 31, 2026 2.93% $0.00 0.00%
Anchorage Advisors, LLC 1.75M Mar 31, 2026 2.67% $2.45 0.00%
Legal & General Group PLC 1.66M Mar 31, 2026 2.54% $0.00 5.30%
State Street Corp 1.35M Mar 31, 2026 2.06% $0.00 4.22%
Forbes J M & Co 1.03M Mar 31, 2026 1.57% $0.53 -1.16%
Geode Capital Management, LLC 1.01M Mar 31, 2026 1.55% $0.00 0.98%
The Goldman Sachs Group Inc 929.86K Mar 31, 2026 1.42% $0.00 1.15%
Allianz Asset Management AG 700.52K Mar 31, 2026 1.07% $0.00 55.74%
SB INVESTMENT ADVISERS (UK) LTD 610.73K Mar 31, 2026 0.93% $0.05 0.00%
UBS Group AG 582.80K Mar 31, 2026 0.89% $0.00 19.08%
Vanguard Portfolio Management, LLC 565.65K Mar 31, 2026 0.87% $0.00 0.00%
Prescott Group Capital Management LLC 541.85K Mar 31, 2026 0.83% $0.33 0.00%
Millennium Management LLC 487.96K Mar 31, 2026 0.75% $0.00 897.85%
Bank of America Corp 476.91K Mar 31, 2026 0.73% $0.00 -20.85%
Tudor Investment Corp Et AL 464.66K Mar 31, 2026 0.71% $0.01 139.56%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Scottish Mortgage Ord 2.39M 3.66% ▲ 0.00% May 31, 2026
2 L&G Artificial Intelligence ETF 1.65M 2.52% ▲ 0.00% Jun 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 1.49M 2.28% ▲ 4.01% Jun 30, 2026
4 iShares Russell 2000 ETF 1.26M 1.93% ▲ 0.60% Jun 30, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 549.89K 0.84% ▲ 11.11% Jun 30, 2026
6 PIMCO RAE US Small Instl 489.37K 0.75% ▲ 43.10% Mar 31, 2026
7 PIMCO RAE US Small 489.37K 0.75% ▲ 43.10% Mar 31, 2026
8 iShares Russell 2000 Value ETF 443.48K 0.68% ▼ 0.69% Jun 30, 2026
9 Fidelity Small Cap Index 422.31K 0.65% ▲ 0.84% Apr 30, 2026
10 iShares Biotechnology ETF 359.96K 0.55% ▲ 1.05% Jun 30, 2026

Financial Highlights

Market Cap: $486.67M
EBITDA: $-262.49M
Book Value: $7.19
Earnings/Share: $-5.45
Profit Margin: -201.05%
Operating Margin: -366.51%
ROA (TTM): -16.16%
ROE (TTM): -56.03%
Revenue (TTM): $151.40M
Revenue/Share (TTM): $2.67
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -49.10%

Valuation Metrics

Enterprise Value: $523.91M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 53.36M
Shares Float: 47.85M
% Insiders: 460.10%
% Institutions: 6,872.80%
Short % Float: 10.09%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$170.16M
Cost of Goods Sold
adjust
$-31.52M
Gross Profit
subtotal
$138.63M
SG&A
adjust
$-183.29M
R&D
adjust
$-243.77M
Other Operating Expense
adjust
$-26.85M
Operating Income
subtotal
$-315.28M
Other / Non-Operating Items
adjust
$2.52M
Net Income
subtotal
$-312.76M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DNA.US!